Literature DB >> 32648004

Macroglial diversity: white and grey areas and relevance to remyelination.

Inge L Werkman1,2, Dennis H Lentferink1, Wia Baron3.   

Abstract

Macroglia, comprising astrocytes and oligodendroglial lineage cells, have long been regarded as uniform cell types of the central nervous system (CNS). Although regional morphological differences between these cell types were initially described after their identification a century ago, these differences were largely ignored. Recently, accumulating evidence suggests that macroglial cells form distinct populations throughout the CNS, based on both functional and morphological features. Moreover, with the use of refined techniques including single-cell and single-nucleus RNA sequencing, additional evidence is emerging for regional macroglial heterogeneity at the transcriptional level. In parallel, several studies revealed the existence of regional differences in remyelination capacity between CNS grey and white matter areas, both in experimental models for successful remyelination as well as in the chronic demyelinating disease multiple sclerosis (MS). In this review, we provide an overview of the diversity in oligodendroglial lineage cells and astrocytes from the grey and white matter, as well as their interplay in health and upon demyelination and successful remyelination. In addition, we discuss the implications of regional macroglial diversity for remyelination in light of its failure in MS. Since the etiology of MS remains unknown and only disease-modifying treatments altering the immune response are available for MS, the elucidation of macroglial diversity in grey and white matter and its putative contribution to the observed difference in remyelination efficiency between these regions may open therapeutic avenues aimed at enhancing endogenous remyelination in either area.

Entities:  

Keywords:  Astrocyte; Heterogeneity; Oligodendrocyte; Plasticity; Remyelination

Year:  2020        PMID: 32648004     DOI: 10.1007/s00018-020-03586-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  304 in total

Review 1.  Astrocyte loss and astrogliosis in neuroinflammatory disorders.

Authors:  Stephanie Hostenbach; Melissa Cambron; Miguel D'haeseleer; Ron Kooijman; Jacques De Keyser
Journal:  Neurosci Lett       Date:  2013-10-12       Impact factor: 3.046

2.  Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.

Authors:  Eva M M Strijbis; Evert-Jan Kooi; Paul van der Valk; Jeroen J G Geurts
Journal:  J Neuropathol Exp Neurol       Date:  2017-05-01       Impact factor: 3.685

Review 3.  The molecular basis of neurodegeneration in multiple sclerosis.

Authors:  Hans Lassmann; Jack van Horssen
Journal:  FEBS Lett       Date:  2011-08-16       Impact factor: 4.124

4.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

5.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

6.  The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation.

Authors:  Fraser J Sim; Chao Zhao; Jacques Penderis; Robin J M Franklin
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

7.  Cortical remyelination: a new target for repair therapies in multiple sclerosis.

Authors:  Ansi Chang; Susan M Staugaitis; Ranjan Dutta; Courtney E Batt; Kathryn E Easley; Anthony M Chomyk; V Wee Yong; Robert J Fox; Grahame J Kidd; Bruce D Trapp
Journal:  Ann Neurol       Date:  2012-10-17       Impact factor: 10.422

8.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain.

Authors:  Frederico A C Azevedo; Ludmila R B Carvalho; Lea T Grinberg; José Marcelo Farfel; Renata E L Ferretti; Renata E P Leite; Wilson Jacob Filho; Roberto Lent; Suzana Herculano-Houzel
Journal:  J Comp Neurol       Date:  2009-04-10       Impact factor: 3.215

Review 9.  Pathophysiology of multiple sclerosis.

Authors:  Thomas Korn
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

10.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Authors:  J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

View more
  4 in total

1.  The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation.

Authors:  Cinzia Volonté; Savina Apolloni; Susanna Amadio
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 2.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

Review 3.  The Cellular Senescence Stress Response in Post-Mitotic Brain Cells: Cell Survival at the Expense of Tissue Degeneration.

Authors:  Eric Sah; Sudarshan Krishnamurthy; Mohamed Y Ahmidouch; Gregory J Gillispie; Carol Milligan; Miranda E Orr
Journal:  Life (Basel)       Date:  2021-03-11

Review 4.  Myelin Repair: From Animal Models to Humans.

Authors:  Myriam Cayre; Marie Falque; Océane Mercier; Karine Magalon; Pascale Durbec
Journal:  Front Cell Neurosci       Date:  2021-04-14       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.